Literature DB >> 20595673

Endothelial activation in lacunar stroke subtypes.

Iris L H Knottnerus1, Jose W P Govers-Riemslag, Karly Hamulyak, Rob P W Rouhl, Julie Staals, Henri M H Spronk, Rene van Oerle, Elisabeth P M van Raak, Jan Lodder, Hugo ten Cate, Robert J van Oostenbrugge.   

Abstract

BACKGROUND AND
PURPOSE: Lacunar stroke (LS) can be subtyped according to the absence (isolated lacunar infarct [ILA]) or presence of concomitant white matter lesions (WML) and/or asymptomatic lacunar infarcts. Endothelial activation is thought to play a pivotal role in the subtype with WML and/or asymptomatic lacunar infarcts. The aim of this study was to evaluate whether endothelial activation is associated with WML and/or asymptomatic lacunar infarcts in LS patients. Here, we determined levels of circulating blood markers of endothelial function in LS patients.
METHODS: In 149 patients, all of whom had brain-MRI, levels of tissue plasminogen activator (tPA), plasminogen activator inhibitor type 1 (PAI-1), tPA-PAI-1 complex, von Willebrand factor, tissue factor, thrombomodulin, and coagulation factor VIII were determined. Levels of blood markers were related to subtypes of LS and adjusted for age, gender, and vascular risk factors.
RESULTS: In subtypes of LS, tPA activity was increased in patients with WML (0.79 IU/mL vs 0.44 IU/mL for ILA; P=0.02) and PAI-1-antigen levels were lowest in patients with WML (27.5 ng/mL vs 44.0 ng/mL for ILA; P=0.02). The association between WML and PAI-1 remained significant after multivariable analysis (OR, 0.99; 95% CI, 0.98-1.00 per ng/mL change of PAI-1; P=0.04).
CONCLUSIONS: We found further evidence for the hypothesis of endothelial activation in the subtype of LS caused by a diffuse small vessel vasculopathy, as we found higher levels of tPA in patients with concomitant extensive WML than in those with ILA. Second, low levels of PAI-1 were associated with WML. We postulate that differences in activity of components of the fibrinolytic system might contribute to WML development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20595673     DOI: 10.1161/STROKEAHA.109.576223

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  22 in total

Review 1.  Factoring in Factor VIII With Acute Ischemic Stroke.

Authors:  James E Siegler; Alyana Samai; Karen C Albright; Amelia K Boehme; Sheryl Martin-Schild
Journal:  Clin Appl Thromb Hemost       Date:  2015-02-10       Impact factor: 2.389

Review 2.  Vascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research.

Authors:  Richard S Beard; Shawn E Bearden
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-22       Impact factor: 4.733

Review 3.  Vascular mechanisms in the pathogenesis of stroke.

Authors:  Cristina Sierra; Antonio Coca; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

Review 4.  The pathobiology of vascular dementia.

Authors:  Costantino Iadecola
Journal:  Neuron       Date:  2013-11-20       Impact factor: 17.173

5.  Effects of pulsatile minimal invasive extracorporeal circulation on fibrinolysis and organ protection in adult cardiac surgery-a prospective randomized trial.

Authors:  Angelika Graßler; Robert Bauernschmitt; Irene Guthoff; Andreas Kunert; Markus Hoenicka; Günter Albrecht; Andreas Liebold
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

Review 6.  Endothelial cells and human cerebral small vessel disease.

Authors:  Atticus H Hainsworth; Asho T Oommen; Leslie R Bridges
Journal:  Brain Pathol       Date:  2015-01       Impact factor: 6.508

7.  Estimating the magnitude of genetic factors by calculating the genetic relative risk of stroke in first-ever lacunar stroke patients.

Authors:  Iris L H Knottnerus; Marij Gielen; Jan Lodder; Rob P W Rouhl; Julie Staals; Robert Vlietinck; Robert J van Oostenbrugge
Journal:  PLoS One       Date:  2011-06-29       Impact factor: 3.240

8.  Connecting cerebral white matter lesions and hypertensive target organ damage.

Authors:  Cristina Sierra; Alfons López-Soto; Antonio Coca
Journal:  J Aging Res       Date:  2011-08-03

9.  Small vessel cerebrovascular disease: the past, present, and future.

Authors:  Réza Behrouz; Ali R Malek; Michel T Torbey
Journal:  Stroke Res Treat       Date:  2012-01-24

10.  Xueshuantong improves cerebral blood perfusion in elderly patients with lacunar infarction.

Authors:  Qifeng Gui; Yunmei Yang; Shihong Ying; Minming Zhang
Journal:  Neural Regen Res       Date:  2013-03-25       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.